538964 Stock Overview
Mercury Laboratories Limited develops, manufactures, markets, distributes, and sells pharmaceutical drugs, medicines, and formulations for mother and child healthcare in South East Asia, Africa, Latin America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Mercury Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹895.10 |
| 52 Week High | ₹1,303.00 |
| 52 Week Low | ₹535.10 |
| Beta | 0.37 |
| 1 Month Change | 3.36% |
| 3 Month Change | -25.41% |
| 1 Year Change | 39.99% |
| 3 Year Change | 35.35% |
| 5 Year Change | 193.48% |
| Change since IPO | 2,655.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 538964 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -4.0% | -2.8% | -1.5% |
| 1Y | 40.0% | 54.9% | 45.0% |
Return vs Industry: 538964 underperformed the Indian Pharmaceuticals industry which returned 54.9% over the past year.
Return vs Market: 538964 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
| 538964 volatility | |
|---|---|
| 538964 Average Weekly Movement | 7.7% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 538964's share price has been volatile over the past 3 months.
Volatility Over Time: 538964's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 537 | Rajendra Shah | www.mercurylabs.com |
Mercury Laboratories Limited develops, manufactures, markets, distributes, and sells pharmaceutical drugs, medicines, and formulations for mother and child healthcare in South East Asia, Africa, Latin America, and internationally. It offers antihypertensive, PCOS and uterine disorders, galactagogue, haemostat, iron and vitamins, preterm labor management, antiemetic, PPI, zinc supplement, antiallergic, digestive enzyme, promolact, child care, cardiovascular and respiratory system, eye, gastro-intestinal system, analgesics/anti-inflammatory/antipyretic, antibiotic, anti-infective, and other products for gynec, pediatric, surgeon, and physician. The company exports its formulations, such as anti-inflammatory, antimalarial, digestive, hypoglycemic, multivitamin, CNS, pain management, gynec, CVS, cold and cough, miscellaneous, and other formulations, as well as antibiotic, antifungal, and antiviral formulations.
Mercury Laboratories Limited Fundamentals Summary
| 538964 fundamental statistics | |
|---|---|
| Market cap | ₹1.07b |
| Earnings (TTM) | ₹41.11m |
| Revenue (TTM) | ₹776.23m |
26.1x
P/E Ratio1.4x
P/S RatioIs 538964 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 538964 income statement (TTM) | |
|---|---|
| Revenue | ₹776.23m |
| Cost of Revenue | ₹340.89m |
| Gross Profit | ₹435.35m |
| Other Expenses | ₹394.24m |
| Earnings | ₹41.11m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 34.25 |
| Gross Margin | 56.08% |
| Net Profit Margin | 5.30% |
| Debt/Equity Ratio | 12.8% |
How did 538964 perform over the long term?
See historical performance and comparison